These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 15342386)

  • 1. Hath1, down-regulated in colon adenocarcinomas, inhibits proliferation and tumorigenesis of colon cancer cells.
    Leow CC; Romero MS; Ross S; Polakis P; Gao WQ
    Cancer Res; 2004 Sep; 64(17):6050-7. PubMed ID: 15342386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for Hath1, a bHLH transcription factor, in colon adenocarcinoma.
    Leow CC; Polakis P; Gao WQ
    Ann N Y Acad Sci; 2005 Nov; 1059():174-83. PubMed ID: 16382053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index.
    Wilson JW; Deed RW; Inoue T; Balzi M; Becciolini A; Faraoni P; Potten CS; Norton JD
    Cancer Res; 2001 Dec; 61(24):8803-10. PubMed ID: 11751402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer.
    Tsuchiya K; Nakamura T; Okamoto R; Kanai T; Watanabe M
    Gastroenterology; 2007 Jan; 132(1):208-20. PubMed ID: 17241872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hath1 inhibits proliferation of colon cancer cells probably through up-regulating expression of Muc2 and p27 and down-regulating expression of cyclin D1.
    Zhu DH; Niu BL; Du HM; Ren K; Sun JM; Gong JP
    Asian Pac J Cancer Prev; 2012; 13(12):6349-55. PubMed ID: 23464457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hath1 gene transfer inhibits the proliferation of colonic cancer cells in vitro].
    Zhu DH; Gong JP; Ren K; Sun JM; Wei SD
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1005-8. PubMed ID: 20501407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis.
    Gersemann M; Becker S; Kübler I; Koslowski M; Wang G; Herrlinger KR; Griger J; Fritz P; Fellermann K; Schwab M; Wehkamp J; Stange EF
    Differentiation; 2009 Jan; 77(1):84-94. PubMed ID: 19281767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HATH1 expression in mucinous cancers of the colorectum and related lesions.
    Park ET; Oh HK; Gum JR; Crawley SC; Kakar S; Engel J; Leow CC; Gao WQ; Kim YS
    Clin Cancer Res; 2006 Sep; 12(18):5403-10. PubMed ID: 17000673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ING4 induces cell growth inhibition in human lung adenocarcinoma A549 cells by means of Wnt-1/beta-catenin signaling pathway.
    Li X; Cai L; Liang M; Wang Y; Yang J; Zhao Y
    Anat Rec (Hoboken); 2008 May; 291(5):593-600. PubMed ID: 18399550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hath1 up-regulates gastric mucin gene expression in gastric cells.
    Sekine A; Akiyama Y; Yanagihara K; Yuasa Y
    Biochem Biophys Res Commun; 2006 Jun; 344(4):1166-71. PubMed ID: 16647036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2F4 expression is required for cell cycle progression of normal intestinal crypt cells and colorectal cancer cells.
    Garneau H; Paquin MC; Carrier JC; Rivard N
    J Cell Physiol; 2009 Nov; 221(2):350-8. PubMed ID: 19562678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P27KiP1 overexpression inhibits the growth and doxorubicin sensitivity of HT29 human colon cancer cells in vivo.
    Dimanche-Boitrel MT; Micheau O; France D; Hammann A; Duchamp O; Genne P; Solary E
    Anticancer Res; 2000; 20(2A):849-52. PubMed ID: 10810365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of c-Met inhibits growth in the liver of human colorectal carcinoma cells.
    Herynk MH; Stoeltzing O; Reinmuth N; Parikh NU; Abounader R; Laterra J; Radinsky R; Ellis LM; Gallick GE
    Cancer Res; 2003 Jun; 63(11):2990-6. PubMed ID: 12782608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity.
    Xue J; Li X; Jiao S; Wei Y; Wu G; Fang J
    Gastroenterology; 2010 Feb; 138(2):606-15. PubMed ID: 19786027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential roles of Hath1, MUC2 and P27Kip1 in relation with gamma-secretase inhibition in human colonic carcinomas: a translational study.
    Souazé F; Bou-Hanna C; Kandel C; Leclair F; Devallière J; Charreau B; Bézieau S; Mosnier JF; Laboisse CL
    PLoS One; 2013; 8(2):e55904. PubMed ID: 23409082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein Kinase-zeta inhibits collagen I-dependent and anchorage-independent growth and enhances apoptosis of human Caco-2 cells.
    Mustafi R; Cerda S; Chumsangsri A; Fichera A; Bissonnette M
    Mol Cancer Res; 2006 Sep; 4(9):683-94. PubMed ID: 16940160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted inactivation of p27kip1 is sufficient for large and small intestinal tumorigenesis in the mouse, which can be augmented by a Western-style high-risk diet.
    Yang W; Bancroft L; Nicholas C; Lozonschi I; Augenlicht LH
    Cancer Res; 2003 Aug; 63(16):4990-6. PubMed ID: 12941825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumorigenesis in p27/p53- and p18/p53-double null mice: functional collaboration between the pRb and p53 pathways.
    Damo LA; Snyder PW; Franklin DS
    Mol Carcinog; 2005 Feb; 42(2):109-20. PubMed ID: 15584024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered phenotype of HT29 colonic adenocarcinoma cells following expression of the DCC gene.
    Velcich A; Corner G; Palumbo L; Augenlicht L
    Oncogene; 1999 Apr; 18(16):2599-606. PubMed ID: 10353603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.